The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
CD40 and autoimmunity: The dark side of a great activator
Open accessAbstract
CD40 is a Tumor Necrosis Factor Receptor superfamily member expressed by immune and non-immune cells. CD40:CD154 interactions mediate T-dependent B cell responses and efficient T cell priming. Thus, CD40 is a likely candidate to play roles in autoimmune diseases in which activated T and B cells cause pathology. Diseases in which CD40 plays a pathogenic role include autoimmune thyroiditis, type 1 diabetes, inflammatory bowel disease, psoriasis, multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus. This review discusses the role of CD40:CD154 interaction in human and mouse autoimmunity, human polymorphisms associated with disease incidence, and disrupting CD40:CD154 interactions as an autoimmune therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY
Bottazzo, G., Hanafusa, T., Pujol-Borrell, R., & Feldmann, M. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90629-3 · Cited by 1,256
Evidence that cytokines play a role in rheumatoid arthritis
Brennan, F. M., & McInnes, I. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36389 · Cited by 1,103
The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
André, P., Prasad, K. S. S., Denis, C. V., He, M., Papalia, J. M., Hynes, R. O., Phillips, D. R., & Wagner, D. D. (2002) · Nature Medicine · doi:10.1038/nm0302-247 · Cited by 726
Boumpas, D. T., Furie, R., Manzi, S., Illei, G. G., Wallace, D. J., Balow, J. E., Vaishnaw, A., & on behalf of the BG9588 Lupus Nephritis Trial Group (2003) · Arthritis & Rheumatism · doi:10.1002/art.10856 · Cited by 618
Characteristics of Intestinal Dendritic Cells in Inflammatory Bowel Diseases
Hart, A. L., Al-Hassi, H. O., Rigby, R. J., Bell, S. J., Emmanuel, A. V., Knight, S. C., Kamm, M. A., & Stagg, A. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.013 · Cited by 564
Delineating the Genetic Basis of Systemic Lupus Erythematosus
Wakeland, E. K., Liu, K., Graham, R. R., & Behrens, T. W. (2001) · Immunity · doi:10.1016/s1074-7613(01)00201-1 · Cited by 556
Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis
Homey, B., Dieu-Nosjean, M.-C., Wiesenborn, A., Massacrier, C., Pin, J.-J., Oldham, E., Catron, D., Buchanan, M. E., Müller, A., deWaal Malefyt, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6621 · Cited by 537
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
Raychaudhuri, S., Remmers, E. F., Lee, A. T., Hackett, R., Guiducci, C., Burtt, N. P., Gianniny, L., Korman, B. D., Padyukov, L., Kurreeman, F. A. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.233 · Cited by 535
Desai-Mehta, A., Lu, L., Ramsey-Goldman, R., & Datta, S. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118643 · Cited by 517
Akiyama, T., Shimo, Y., Yanai, H., Qin, J., Ohshima, D., Maruyama, Y., Asaumi, Y., Kitazawa, J., Takayanagi, H., Penninger, J. M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.06.015 · Cited by 503
CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.
Gerritse, K., Laman, J. D., Noelle, R. J., Aruffo, A., Ledbetter, J. A., Boersma, W. J., & Claassen, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2499 · Cited by 488
Getting under the skin: the immunogenetics of psoriasis
Bowcock, A. M., & Krueger, J. G. (2005) · Nature Reviews Immunology · doi:10.1038/nri1689 · Cited by 484
Prevention of Collagen-Induced Arthritis with an Antibody to gp39, the Ligand for CD40
Durie, F. H., Fava, R. A., Foy, T. M., Aruffo, A., Ledbetter, J. A., & Noelle, R. J. (1993) · Science · doi:10.1126/science.7689748 · Cited by 457
Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H., & Tisch, R. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3912 · Cited by 456
Lowes, M. A., Chamian, F., Abello, M. V., Fuentes-Duculan, J., Lin, S.-L., Nussbaum, R., Novitskaya, I., Carbonaro, H., Cardinale, I., Kikuchi, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509736102 · Cited by 456
Grewal, I. S., Foellmer, H. G., Grewal, K. D., Xu, J., Hardardottir, F., Baron, J. L., Janeway, C. A., & Flavell, R. A. (1996) · Science · doi:10.1126/science.273.5283.1864 · Cited by 418
Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
Mohan, C., Shi, Y., Laman, J. D., & Datta, S. K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1470 · Cited by 364
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
Koshy, M., Berger, D., & Crow, M. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118855 · Cited by 359
Noss, E. H., & Brenner, M. B. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00648.x · Cited by 357
Tokunaga, M., Saito, K., Kawabata, D., Imura, Y., Fujii, T., Nakayamada, S., Tsujimura, S., Nawata, M., Iwata, S., Azuma, T., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.057885 · Cited by 343
Stuber, E., Strober, W., & Neurath, M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.693 · Cited by 338
Kalunian, K. C., Davis, J. C., Merrill, J. T., Totoritis, M. C., Wofsy, D., & for the IDEC‐131 Lupus Study Group (2002) · Arthritis & Rheumatism · doi:10.1002/art.10681 · Cited by 336
Balashov, K. E., Smith, D. R., Khoury, S. J., Hafler, D. A., & Weiner, H. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.599 · Cited by 320
Abrams, J. R., Kelley, S. L., Hayes, E., Kikuchi, T., Brown, M. J., Kang, S., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Linsley, P. S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.681 · Cited by 318
Autoimmune diseases: insights from genome-wide association studies
Lettre, G., & Rioux, J. D. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn246 · Cited by 317
Fernández, M., Alarcón, G. S., Calvo‐alén, J., Andrade, R., McGwin, G., Vilá, L. M., Reveille, J. D., & LUMINA Study Group (2007) · Arthritis Care & Research · doi:10.1002/art.22672 · Cited by 272
Autoantibodies in type 1 diabetes
Taplin, C. E., & Barker, J. M. (2008) · Autoimmunity · doi:10.1080/08916930701619169 · Cited by 250
Balasa, B., Krahl, T., Patstone, G., Lee, J., Tisch, R., McDevitt, H. O., & Sarvetnick, N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.9.4620 · Cited by 244
Grammer, A. C., Slota, R., Fischer, R., Gur, H., Girschick, H., Yarboro, C., Illei, G. G., & Lipsky, P. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19301 · Cited by 230
Yellin, M. J., Winikoff, S., Fortune, S. M., Baum, D., Crow, M. K., Lederman, S., & Chess, L. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.2.209 · Cited by 228
Grammer, A. C., Slota, R., Fischer, R., Gur, H., Girschick, H., Yarboro, C., Illei, G. G., & Lipsky, P. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319301 · Cited by 228
Early, G. S., Zhao, W., & Burns, C. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.7.3159 · Cited by 218
Howard, L. M., Miga, A. J., Vanderlugt, C. L., Canto, M. C. D., Laman, J. D., Noelle, R. J., & Miller, S. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5388 · Cited by 217
Becher, B., Durell, B. G., Miga, A. V., Hickey, W. F., & Noelle, R. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.967 · Cited by 213
Jacobson, E. M., Concepcion, E., Oashi, T., & Tomer, Y. (2005) · Endocrinology · doi:10.1210/en.2004-1617 · Cited by 209
Tomer, Y., Concepcion, E., & Greenberg, D. A. (2002) · Thyroid · doi:10.1089/105072502321085234 · Cited by 207
Iezzi, G., Sonderegger, I., Ampenberger, F., Schmitz, N., Marsland, B. J., & Kopf, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810769106 · Cited by 203
Kalled, S. L., Cutler, A. H., Datta, S. K., & Thomas, D. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2158 · Cited by 199
Jacobson, E. M., & Tomer, Y. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.02.006 · Cited by 198
TRAF Proteins in CD40 Signaling
Bishop, G. A., Moore, C. R., Xie, P., Stunz, L. L., & Kraus, Z. J. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-70630-6_11 · Cited by 194
Self-citationFunctional CD40 ligand is expressed by T cells in rheumatoid arthritis.
MacDonald, K. P., Nishioka, Y., Lipsky, P. E., & Thomas, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119781 · Cited by 168
Ponomarev, E. D., Shriver, L. P., & Dittel, B. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1402 · Cited by 167
The effect of anti‐CD40 ligand antibody on B cells in human systemic lupus erythematosus
Huang, W., Sinha, J., Newman, J., Reddy, B., Budhai, L., Furie, R., Vaishnaw, A., & Davidson, A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10273 · Cited by 165
Issazadeh, S., Navikas, V., Schaub, M., Sayegh, M., & Khoury, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1104 · Cited by 163
Danese, S., Sans, M., Scaldaferri, F., Sgambato, A., Rutella, S., Cittadini, A., Piqué, J. M., Panes, J., Katz, J. A., Gasbarrini, A., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2617 · Cited by 162
The Role of CD40–CD154 Interactions in Autoimmunity and the Benefit of Disrupting this Pathway
Toubi, E., & Shoenfeld, Y. (2004) · Autoimmunity · doi:10.1080/08916930400002386 · Cited by 161
Cutting Edge: Ectopic Expression of CD40 Ligand on B Cells Induces Lupus-Like Autoimmune Disease
Higuchi, T., Aiba, Y., Nomura, T., Matsuda, J., Mochida, K., Suzuki, M., Kikutani, H., Honjo, T., Nishioka, K., & Tsubata, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.9 · Cited by 160
Tai, Y.-T., Li, X., Tong, X., Santos, D., Otsuki, T., Catley, L., Tournilhac, O., Podar, K., Hideshima, T., Schlossman, R., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4125 · Cited by 158
The multifaceted roles of TRAFs in the regulation of B-cell function
Bishop, G. A. (2004) · Nature reviews. Immunology · doi:10.1038/nri1462 · Cited by 157
Self-citationLiu, Z., Colpaert, S. A., D’Haens, G., Kasran, A., de Boer, M., Rutgeerts, P., Geboes, K. J., & Ceuppens, J. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.4049 · Cited by 146
Goules, A. V., Tzioufas, A. G., Manousakis, M., Kirou, K. A., Crow, M. K., & Routsias, J. G. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.02.002 · Cited by 144
Mehling, A., Loser, K., Varga, G., Metze, D., Luger, T. A., Schwarz, T., Grabbe, S., & Beissert, S. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.615 · Cited by 143
Mariño, E., Batten, M., Groom, J. R., Walters, S. N., Liuwantara, D., Mackay, F., & Grey, S. T. (2007) · Diabetes · doi:10.2337/db07-0589 · Cited by 131
Liu, Z., Geboes, K. J., Colpaert, S. A., Overbergh, L., Mathieu, C., Heremans, H., de Boer, M., Boon, L., D’Haens, G., Rutgeerts, P. J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.6005 · Cited by 126
CD40-CD40L and Platelet Function: Beyond Hemostasis
Freedman, J. E. (2003) · Circulation Research · doi:10.1161/01.res.0000074030.98009.ff · Cited by 125
Genetic risk factors for rheumatoid arthritis differ in caucasian and Korean populations
Lee, H., Korman, B. D., Le, J. M., Kastner, D. L., Remmers, E. F., Gregersen, P. K., & Bae, S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24245 · Cited by 119
Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes
Wagner, D. H., Vaitaitis, G. M., Sanderson, R. J., Poulin, M., Dobbs, C. M., & HASKINS, K. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052247099 · Cited by 112
Effects of anti‐CD154 treatment on B cells in murine systemic lupus erythematosus
Wang, X., Huang, W., Schiffer, L. E., Mihara, M., Akkerman, A., Hiromatsu, K., & Davidson, A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10929 · Cited by 112
Shimaoka, Y., Attrep, J. F., Hirano, T., Ishihara, K., Suzuki, R., Toyosaki, T., Ochi, T., & Lipsky, P. E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3162 · Cited by 109
Nanji, S. A., Hancock, W. W., Luo, B., Schur, C. D., Pawlick, R. L., Zhu, L. F., Anderson, C. C., & Shapiro, A. M. J. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db04-1154 · Cited by 103
CD4+CD25+ T-Cells Control Autoimmunity in the Absence of B-Cells
Mariño, E., Villanueva, J. E., Walters, S. N., Liuwantara, D., Mackay, F., & Grey, S. T. (2009) · Diabetes · doi:10.2337/db08-1504 · Cited by 103
Therapeutic Interventions Targeting CD40L (CD154) and CD40: The Opportunities and Challenges
Law, C., & Grewal, I. S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_2 · Cited by 102
Berner, B. R., Wolf, G., Hummel, K. M., Muller, G. A., & Reuss-Borst, M. A. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.3.190 · Cited by 102
Jacobson, E. M., Huber, A. K., Akeno, N., Sivak, M. A., Li, C. W., Concepcion, E. S., Ho, K., & Tomer, Y. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364375 · Cited by 98
Suppression of murine thyroiditis via blockade of the CD40–CD40L interaction
Carayanniotis, G., Masters, S. R., & Noelle, R. J. (1997) · Immunology · doi:10.1111/j.1365-2567.1997.00421.x · Cited by 97
de Jong, Y. P., Comiskey, M., Kalled, S. L., Mizoguchi, E., Flavell, R. A., Bhan, A. K., & Terhorst, C. (2000) · Gastroenterology · doi:10.1053/gast.2000.16485 · Cited by 92
Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice
Clegg, C. H., Rulffes, J. T., Haugen, H. S., Hoggatt, I. H., Aruffo, A. A., Durham, S. K., Farr, A. G., & Hollenbaugh, D. (1997) · International Immunology · doi:10.1093/intimm/9.8.1111 · Cited by 91
Lee, H., Jeon, H., Song, E., Han, M., Park, S., Lee, S. I., Yun, H., Kim, J., Kim, J., Lee, Y., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21873 · Cited by 89
Thompson, S. D., Moroldo, M. B., Guyer, L., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20425 · Cited by 89
Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis
Tan, J. R., Town, T., Paris, D., Placzek, A. N., Parker, T. A., Crawford, F., Yu, H., Humphrey, J., & MULLAN, M. J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00053-3 · Cited by 88
Kasran, A., Boon, L., Wortel, C. H., van Hogezand, R. A., Schreiber, S., Goldin, E., BOER, M. D., Geboes, K., Rutgeerts, P. J., & Ceuppens, J. L. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02526.x · Cited by 85
Katsiari, C. G., Liossis, S. C., Souliotis, V. L., Dimopoulos, M. A., Manoussakis, M. N., & Sfikakis, P. P. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5172 · Cited by 84
Becher, B., Blain, M., & Antel, J. P. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00152-6 · Cited by 73
Smith, T. J., Sciaky, D., Phipps, R. P., & Jennings, T. A. (1999) · Thyroid · doi:10.1089/thy.1999.9.749 · Cited by 70
CD40–CD40 Ligand Interaction Activates Proinflammatory Pathways in Pancreatic Islets
Barbé‐Tuana, F. M., Klein, D., Ichii, H., Berman, D. M., Coffey, L. C. K., Kenyon, N. S., Ricordi, C., & Pastori, R. L. (2006) · Diabetes · doi:10.2337/db05-1673 · Cited by 68
Inflammatory bowel disease: Genetic and epidemiologic considerations
Cho, J. H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.338 · Cited by 65
Association of CD40 Gene Polymorphism (C-1T) with Susceptibility and Phenotype of Graves' Disease
Kuryłowicz, A., Kula, D., Płoski, R., Skórka, A., Jurecka‐Lubieniecka, B., Żebracka, J., Steinhof-Radwańska, K., Hasse-Lazar, K., Hiromatsu, Y., Jarząb, B., et al. (2005) · Thyroid · doi:10.1089/thy.2005.15.1119 · Cited by 64
Samoilova, E. B., Horton, J. L., Zhang, H., & Chen, Y. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050145 · Cited by 61
Expression of CD40 and CD40 Ligand among Cell Populations within Rheumatoid Synovial Compartment
Liu, M.-F., Chao, S.-C., Wang, C., et al. (2001) · Autoimmunity · doi:10.3109/08916930109001958 · Cited by 59
Komura, K., Fujimoto, M., Yanaba, K., Matsushita, T., Matsushita, Y., Horikawa, M., Ogawa, F., Shimizu, K., Hasegawa, M., Takehara, K., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.073387 · Cited by 58
A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes
Waid, D., Wagner, R., Putnam, A. L., Vaitaitis, G. M., Pennock, N. D., Calverley, D. C., Gottlieb, P. A., & Wagner, D. H. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.05.003 · Cited by 57
Ferrant, J. L., Benjamin, C. D., Cutler, A. H., Kalled, S. L., Hsu, Y., Garber, E. A., Hess, D. M., Shapiro, R. I., Kenyon, N. S., Harlan, D. M., et al. (2004) · International Immunology · doi:10.1093/intimm/dxh162 · Cited by 57
Boehncke, W., & Schön, M. P. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2007.08.014 · Cited by 56
CD40 on NOD CD4 T cells contributes to their activation and pathogenicity
Baker, R. L., Wagner, D. H., & HASKINS, K. M. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.09.001 · Cited by 55
Coexpression of CD40 and Class II Antigen HLA-DR in Graves’ Disease Thyroid Epithelial Cells
Faure, G. C., Bensoussan, D., Béné, M. C., Aubert, V. D., & Leclère, J. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4391 · Cited by 54
Teleshova, Бао, Kivisäkk, Özenci, V., Mustafa, & Link (2000) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2000.00688.x · Cited by 54
Tamimoto, Y., Horiuchi, T., Tsukamoto, H., Otsuka, J., Mitoma, H., Kimoto, Y., Nakashima, H., Muta, K., Abe, Y., Kiyohara, C., et al. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken071 · Cited by 51
Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade*
Allen, S. D., Rawale, S. V., Whitacre, C. C., & Kaumaya, P. T. P. (2005) · Journal of Peptide Research · doi:10.1111/j.1399-3011.2005.00256.x · Cited by 48
Harigai, M., Hara, M., Kawamoto, M., Kawaguchi, Y., Sugiura, T., Tanaka, M., Nakagawa, M., Ichida, H., Takagi, K., Higami-Ohsako, S., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20340 · Cited by 43
Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis
Schaub, M., Issazadeh‐Navikas, S., Stadlbauer, T. H. W., Peach, R., Sayegh, M. H., & Khoury, S. J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00022-3 · Cited by 37
Pyrovolaki, K., Mavroudi, I., Sidiropoulos, P. I., Eliopoulos, A. G., Boumpas, D. T., & Papadaki, H. Α. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24257 · Cited by 32
Howard, L. M., & Miller, S. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1547 · Cited by 30
Therapeutic Targets of the TNF Superfamily
Grewal, I. S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8 · Cited by 29
Gaffney, P. M., Langefeld, C. D., Graham, R., Ortmann, W. A., Williams, A. H., Rodine, P. R., Moser, K. L., & Behrens, T. W. (2006) · The American Journal of Human Genetics · doi:10.1086/503686 · Cited by 29
Mariño, E., & Grey, S. T. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.04.001 · Cited by 27
Abromson‐Leeman, S. R., Maverakis, E., Bronson, R. T., & Dorf, M. E. (2001) · European Journal of Immunology · Cited by 25
A novel polymorphism of the human CD40 receptor with enhanced function
Peters, A. L., Plenge, R. M., Graham, R., Altshuler, D., Moser, K. L., Gaffney, P. M., & Bishop, G. A. (2008) · Blood · doi:10.1182/blood-2008-02-138925 · Cited by 25
Self-citationCostimulation and Autoimmune Diabetes in BB Rats
Beaudette-Zlatanova, B. C., Whalen, B. J., Zipris, D., Yagita∥, H., Rozing, J., Groen, H., Benjamin, C. D., Hünig, T., Drexhage, H. A., Ansari, M. J., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01227.x · Cited by 21
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Role of Inflammation in Diabetic Retinopathy
Rübsam, A., Parikh, S., & Fort, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040942 · Cited by 750
Zhao, J. H., Stacey, D., Eriksson, N., Macdonald-Dunlop, E., Hedman, Å. K., Kalnapenkis, A., Enroth, S., Cozzetto, D., Digby-Bell, J., Marten, J., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01588-w · Cited by 747
Clinical targeting of the TNF and TNFR superfamilies
Croft, M., Benedict, C. A., & Ware, C. F. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3930 · Cited by 456
Follicular helper T cells in immunity and systemic autoimmunity
Craft, J. E. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.58 · Cited by 375
Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
Croft, M., & Siegel, R. M. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.22 · Cited by 288
Metadata
- Authors
- Peters, A. L., Stunz, L. L., & Bishop, G. A.
- Venue
- Seminars in Immunology
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 21
- Issue
- 5
- Pages
- 293-300
- ISSN
- 1044-5323 (ISSN-L)
- OpenAlex
- W2083764534
- Cited by
- 270
- References
- 103
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.